Ovarian cancer is the leading cause of death from gynecologic malignancies. This article reviews the newer chemotherapeutic agents and treatment strategies available to the practicing clinician. Also discussed are the benefits and shortfalls of the various options for screening, such as ultrasound and tumor markers, as well as the data supporting oral contraceptives and the controversy surrounding prophylactic oophorectomy.